Savvy Updates, 6/16/25: Tandem Teams with Abbott Future Glucose-Ketone Sensor, Vertex’s T1D Cure Trial Fails, Medtronic Becomes Minimed AGAIN, Incretins May Shield Against D Complications, We Don’t Know How GLP-1s Work, High Fasting Insulin Raises Odds for Abnormal Uterine Bleeding, Insulet, Marvel Collab Unveils Comic Book Hero with T1D, FDA Launches AI Tool to Optimize Performance, D Stigma Among Adult T1Ds/T2Ds, Late Dinner Bad for Metabolic Health, AMA Registry to Track Side Effects of GLP-1 Drugs, PBM Lobby Sues Arkansas,

Savvy Updates, 6/16/25: Tandem Teams with Abbott Future Glucose-Ketone Sensor, Vertex’s T1D Cure Trial Fails, Medtronic Becomes Minimed AGAIN, Incretins May Shield Against D Complications, We Don’t Know How GLP-1s Work, High Fasting Insulin Raises Odds for Abnormal Uterine Bleeding, Insulet, Marvel Collab Unveils Comic Book Hero with T1D, FDA Launches AI Tool to Optimize Performance, D Stigma Among Adult T1Ds/T2Ds, Late Dinner Bad for Metabolic Health, AMA Registry to Track Side Effects of GLP-1 Drugs, PBM Lobby Sues Arkansas,

Jun 16, 2025 | Advocacy, Diabetes Business, Eating, Featured, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Tandem Teams with Abbott Future Glucose-Ketone Sensor Vertex’s T1D Cure Trial Fails Medtronic Becomes Minimed AGAIN Incretins May Shield Against D Complications “We Don’t Know How GLP-1s Work” High...
Savvy Updates, 6/9/25: Metabolic Subtypes & BG Responses to Carbs, Semaglutide & D Eye Risks, Dianode-3 Study is RECRUITING, Test Strips NOT Covered by Medicare, High Insulin & Irregular Periods, HIV Med Improves D Eye Disease Vision, Spinal Cord Stim for D Neuropathy Pain, CVS Closing 271 Stores, Mindfulness and/or Hope

Savvy Updates, 6/9/25: Metabolic Subtypes & BG Responses to Carbs, Semaglutide & D Eye Risks, Dianode-3 Study is RECRUITING, Test Strips NOT Covered by Medicare, High Insulin & Irregular Periods, HIV Med Improves D Eye Disease Vision, Spinal Cord Stim for D Neuropathy Pain, CVS Closing 271 Stores, Mindfulness and/or Hope

Jun 9, 2025 | Diabetes Business, Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Metabolic Subtypes & Blood Sugar Responses to Carbohydrates Semaglutide & Diabetic Eye Risks Dianode-3 Study is RECRUITING Newly Diagnosed T1D Young Adults Test Strips NOT Covered by Medicare High Insulin...
Savvy Updates 6/2/2025: Cooking DOES NOT Replace Insulin; Sex-Specific Precision Medicine in D Tech; Clinical Trial Oral Hypoglycemia Medication Cadisegliatin; Fat Cells “Remember” Obesity after Weight Loss; Loneliness is Deadly; TSA Warns of “Juice-Jacking” of Smartphones, Devices at Airports; Clinical Trial for Oral Insulin Tregopil; CVS/Cigna Sue Arkansas Re New PBM Law; Call Centers Being Replaced by AI

Savvy Updates 6/2/2025: Cooking DOES NOT Replace Insulin; Sex-Specific Precision Medicine in D Tech; Clinical Trial Oral Hypoglycemia Medication Cadisegliatin; Fat Cells “Remember” Obesity after Weight Loss; Loneliness is Deadly; TSA Warns of “Juice-Jacking” of Smartphones, Devices at Airports; Clinical Trial for Oral Insulin Tregopil; CVS/Cigna Sue Arkansas Re New PBM Law; Call Centers Being Replaced by AI

Jun 2, 2025 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Cooking DOES NOT Replace Insulin One Size Does Not Fit All: ex-Specific Precision Medicine in D Technology Clinical Trial for Oral Hypoglycemia Medication: Cadisegliatin Fat Cells “Remember” Obesity Even After...
Savvy Updates, 5/27/25: Sequel/Twiist & Abbott’s Future Dual Glucose/Ketone Sensor, Spleen-based Islet Transplants Without Full Immunosuppression, Medtronic Spins Off Diabetes Business, Kakao Healthcare AI-Powered CGM for Japanese Markets, Elvinix (formerly Levicure) Functional Cure in “Stealth Mode”, Tandem Diabetes Pays Roche $36M in Patent Infringement, FDA Removes Hold on Cadisegliatin (vTv Technologies), FDA OKs Susvimo (Roche) for Diabetic Retinopathy, May is Mental Health Awareness Month & National Diabetes Month

Savvy Updates, 5/27/25: Sequel/Twiist & Abbott’s Future Dual Glucose/Ketone Sensor, Spleen-based Islet Transplants Without Full Immunosuppression, Medtronic Spins Off Diabetes Business, Kakao Healthcare AI-Powered CGM for Japanese Markets, Elvinix (formerly Levicure) Functional Cure in “Stealth Mode”, Tandem Diabetes Pays Roche $36M in Patent Infringement, FDA Removes Hold on Cadisegliatin (vTv Technologies), FDA OKs Susvimo (Roche) for Diabetic Retinopathy, May is Mental Health Awareness Month & National Diabetes Month

May 27, 2025 | Diabetes Business, Featured, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Sequel/Twiist & Abbott’s Future Dual Glucose/Ketone Sensor Spleen-based islet transplantation restores glycemic control in T1D without full immunosuppression Medtronic Spins Off Diabetes Business Kakao...
Savvy Updates 5/19/25: Tandem/CapBio Infusion Set Cleared, Test Strips Not Covered by Medicare, Eversense & Sequel/twiist, Abbott Libre Lessens Severity of CV Complications, Call-to-Action to Eliminate Barriers to Access for AIDs, Upcoming CGMs & Patch Pumps, T1Ds Increase Daily Dose of Inhaled Insulin, Tyrosine Kinase 2 (TYK2) Protein Reduces Pancreatic Inflammation, How Much Sugar In Breakfast Foods, Sleep Needs & Your Nationality

Savvy Updates 5/19/25: Tandem/CapBio Infusion Set Cleared, Test Strips Not Covered by Medicare, Eversense & Sequel/twiist, Abbott Libre Lessens Severity of CV Complications, Call-to-Action to Eliminate Barriers to Access for AIDs, Upcoming CGMs & Patch Pumps, T1Ds Increase Daily Dose of Inhaled Insulin, Tyrosine Kinase 2 (TYK2) Protein Reduces Pancreatic Inflammation, How Much Sugar In Breakfast Foods, Sleep Needs & Your Nationality

May 19, 2025 | Advocacy, Diabetes Business, Eating, Featured, Foods, Podcasts, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Tandem/CapBio Infusion Set Cleared (ultimately for extended use to 7 days) Test Strips Not Covered by Medicare Eversense & Sequel twiist Partnership Abbott Libre Lessens the Severity of CV Complications...
Skip to content